Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial

作者：Brian G. Feagan, Bruce E Sands, Corey Allan Siegel, Marla C. Dubinsky, Randy Longman, João Sabino, Olivier Laurent, Allison Y Luo, Jiandong Lu, Deanna D. Nguyen, Ernesto J. Muñoz‐Elías, Heather Llewellyn, Yong Wang, InSock Jang, Janine Bilsborough, Ronald R. Marchelletta, Fadi Towfic, Mark Yen, Jaclyn K. Anderson, Aaron DuVall, Jarosław Kierkuś, Marek Woynarowski, Houssam Al Kharrat, Stephan R. Targan, Dermot P.B. McGovern · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2025 · DOI：10.1016/s2468-1253(25)00071-8 · 被引用次数：34 · 研究领域：Inflammatory Bowel Disease、Rheumatoid Arthritis Research and Therapies、Spondyloarthritis Studies and Treatments